Thomas Haberberger
About Thomas Haberberger
Thomas Haberberger is the Director of Regulatory Affairs at Nektar Therapeutics, a position he has held since 2016. He has extensive experience in regulatory affairs and scientific research, having worked at several prominent biotechnology companies.
Current Role at Nektar Therapeutics
Thomas Haberberger serves as the Director of Regulatory Affairs at Nektar Therapeutics. He has held this position since 2016, contributing to the company's regulatory strategy and compliance efforts. His role involves overseeing regulatory submissions and ensuring that the company's products meet all necessary regulatory requirements.
Previous Experience in Regulatory Affairs
Before joining Nektar Therapeutics, Thomas Haberberger worked in various roles in regulatory affairs. He was an Associate Regulatory Program Director at Genentech from 2013 to 2016, where he managed regulatory submissions and compliance processes. Additionally, he served as a Senior Manager of Regulatory Affairs at The Medicines Company for five months in 2013 and as an Associate Manager of Regulatory Affairs at Gilead Sciences from 2007 to 2012.
Scientific Background and Research Experience
Thomas Haberberger has a solid scientific background, having worked as a Research Scientist II at Exelixis for one year in 2003-2004. He also held a position as a Scientist at Fibrogen, Inc. from 2000 to 2003. His research experience has equipped him with a deep understanding of the scientific principles underlying regulatory processes.
Educational Qualifications
Thomas Haberberger earned a Master of Science degree from the University of Bonn, where he studied from 1989 to 1996. He further advanced his education by obtaining a Doctor of Philosophy degree from the University of Stuttgart, completing his studies from 1997 to 2000. His educational background provides a strong foundation for his work in regulatory affairs.